• August 05, 2010

• Vicept Therapeutics Announces Positive Clinical Study Results of V-101 for the Treatment of the Erythema of Rosacea

• Read More

• June 30, 2010

• Vicept Therapeutics Secures $10 Million to Complete Series A Funding

• Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders

• Read More